Stockhub

Mycenax Biotech Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 August 2022

  • curprev 07:0107:01, 23 August 2022 >Nick 1,003 bytes +1,003 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well..."
Retrieved from "https://stockhub.co/research/Mycenax_Biotech_Inc."